As of June 30, 2026, Zero Candida Technologies Inc. carries a market capitalization of 3.03M, placing it among publicly traded companies globally. Its enterprise value stands at 954,620.74, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.03M |
| Enterprise Value | 954,620.74 |
As of June 30, 2026, Zero Candida Technologies Inc. has 19.53M shares outstanding.
| Shares Outstanding | 19.53M |
These figures are as of June 30, 2026.
| PB Ratio | 3.29 |
| P/TBV Ratio | 3.29 |
As of June 30, 2026, Zero Candida Technologies Inc. maintains a current ratio of 1.71, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.71 |
| Quick Ratio | 1.70 |
| Debt / Equity | 6.84 |
As of the close on October 7, 2026, Zero Candida Technologies Inc.'s stock has declined approximately 60.00% over the past 52 weeks.
| 52-Week Price Change | -60.00% |
| 50-Day Moving Average | 0.17 |
As of June 30, 2026, Zero Candida Technologies Inc. holds 2.14M in cash and equivalents against 63,000.00 in total debt, resulting in a net debt position of -340,000.00. Total book value stands at 921,000.00, with working capital of 894,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 2.14M |
| Total Debt | 63,000.00 |
| Net Debt | -340,000.00 |
| Equity (Book Value) | 921,000.00 |
| Book Value Per Share | 0.05 |
| Working Capital | 894,000.00 |
Already premium?